Tim Hagenacker

5.5k total citations
110 papers, 1.8k citations indexed

About

Tim Hagenacker is a scholar working on Molecular Biology, Genetics and Neurology. According to data from OpenAlex, Tim Hagenacker has authored 110 papers receiving a total of 1.8k indexed citations (citations by other indexed papers that have themselves been cited), including 55 papers in Molecular Biology, 47 papers in Genetics and 25 papers in Neurology. Recurrent topics in Tim Hagenacker's work include Neurogenetic and Muscular Disorders Research (39 papers), Pain Mechanisms and Treatments (21 papers) and Amyloidosis: Diagnosis, Treatment, Outcomes (18 papers). Tim Hagenacker is often cited by papers focused on Neurogenetic and Muscular Disorders Research (39 papers), Pain Mechanisms and Treatments (21 papers) and Amyloidosis: Diagnosis, Treatment, Outcomes (18 papers). Tim Hagenacker collaborates with scholars based in Germany, United States and Qatar. Tim Hagenacker's co-authors include Maria Schäfers, Christoph Kleinschnitz, Dietrich Büsselberg, Markus Leo, Johanna Christina Czeschik, Benjamin Stolte, Andreas Totzeck, Kathrin Kizina, Tobias Ruck and Christiane Schneider‐Gold and has published in prestigious journals such as SHILAP Revista de lepidopterología, Neurology and Scientific Reports.

In The Last Decade

Tim Hagenacker

103 papers receiving 1.8k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Tim Hagenacker Germany 25 658 546 516 333 302 110 1.8k
Nobuyuki Murakami Japan 27 1.2k 1.8× 501 0.9× 233 0.5× 462 1.4× 231 0.8× 112 2.8k
Clifton L. Gooch United States 28 741 1.1× 810 1.5× 423 0.8× 1.1k 3.2× 239 0.8× 70 2.9k
Yue Sun China 25 710 1.1× 667 1.2× 172 0.3× 70 0.2× 255 0.8× 116 1.9k
Zheng Wei United States 26 784 1.2× 335 0.6× 336 0.7× 276 0.8× 136 0.5× 63 2.1k
Tomoya Terashima Japan 21 432 0.7× 334 0.6× 147 0.3× 178 0.5× 133 0.4× 53 1.4k
Gisela Segond von Banchet Germany 24 471 0.7× 1.3k 2.3× 98 0.2× 203 0.6× 136 0.5× 44 2.3k
Luı́s F. Maia Portugal 17 706 1.1× 608 1.1× 96 0.2× 541 1.6× 152 0.5× 35 1.7k
Cora H. Nijboer Netherlands 34 798 1.2× 218 0.4× 349 0.7× 399 1.2× 121 0.4× 66 2.9k
Xiaohuan Gu United States 29 767 1.2× 178 0.3× 419 0.8× 251 0.8× 148 0.5× 50 2.1k
Lusine Danielyan Germany 14 476 0.7× 213 0.4× 336 0.7× 90 0.3× 91 0.3× 38 1.4k

Countries citing papers authored by Tim Hagenacker

Since Specialization
Citations

This map shows the geographic impact of Tim Hagenacker's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Tim Hagenacker with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Tim Hagenacker more than expected).

Fields of papers citing papers by Tim Hagenacker

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Tim Hagenacker. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Tim Hagenacker. The network helps show where Tim Hagenacker may publish in the future.

Co-authorship network of co-authors of Tim Hagenacker

This figure shows the co-authorship network connecting the top 25 collaborators of Tim Hagenacker. A scholar is included among the top collaborators of Tim Hagenacker based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Tim Hagenacker. Tim Hagenacker is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Ullrich, Daniel, Dagmar Führer, Heike Heuer, et al.. (2025). Triiodothyronine treatment in mice improves stroke outcome and reduces blood–brain barrier damage. European Thyroid Journal. 14(1).
2.
Stolte, Benjamin, et al.. (2024). Performance fatigability in adults with spinal muscular atrophy treated long‐term with nusinersen. Muscle & Nerve. 70(6). 1223–1229. 1 indexed citations
3.
Wirth, Brunhilde, et al.. (2024). Oral functions in adult persons with spinal muscular atrophy compared to a healthy control group: a prospective cross-sectional study with a multimodal approach. Orphanet Journal of Rare Diseases. 19(1). 382–382. 1 indexed citations
4.
Thimm, Andreas, et al.. (2023). Corneal confocal microscopy reveals small nerve fibre loss correlating with motor function in adult spinal muscular atrophy. European Journal of Neurology. 30(9). 2821–2827. 2 indexed citations
5.
Dengler, Nora F., Mehdi Chihi, Thiemo Florin Dinger, et al.. (2023). Benign peripheral nerve sheath tumors: an interdisciplinary diagnostic and therapeutic challenge. Neurosurgical Review. 46(1). 205–205. 4 indexed citations
6.
Kessler, Lukas, Pedro Fragoso Costa, David Kersting, et al.. (2022). Quantitative 99mTc-DPD-SPECT/CT assessment of cardiac amyloidosis. Journal of Nuclear Cardiology. 30(1). 101–111. 23 indexed citations
7.
Stolte, Benjamin, Olivia Schreiber‐Katz, René Günther, et al.. (2022). Prevalence of Anti-Adeno-Associated Virus Serotype 9 Antibodies in Adult Patients with Spinal Muscular Atrophy. Human Gene Therapy. 33(17-18). 968–976. 11 indexed citations
8.
9.
10.
Hahn, Andreas, René Günther, Albert C. Ludolph, et al.. (2022). Short-term safety results from compassionate use of risdiplam in patients with spinal muscular atrophy in Germany. Orphanet Journal of Rare Diseases. 17(1). 276–276. 20 indexed citations
11.
Kizina, Kathrin, Daniel Jokisch, Benjamin Stolte, et al.. (2021). Cognitive Impairment in Adult Patients with 5q-Associated Spinal Muscular Atrophy. Brain Sciences. 11(9). 1184–1184. 12 indexed citations
12.
Stolte, Benjamin, Michael Nonnemacher, Kathrin Kizina, et al.. (2021). Nusinersen treatment in adult patients with spinal muscular atrophy: a safety analysis of laboratory parameters. Journal of Neurology. 268(12). 4667–4679. 25 indexed citations
13.
Stolte, Benjamin, Andreas Thimm, Kathrin Kizina, et al.. (2021). Assessment of Bulbar Function in Adult Patients with 5q-SMA Type 2 and 3 under Treatment with Nusinersen. Brain Sciences. 11(9). 1244–1244. 20 indexed citations
14.
Stolte, Benjamin, Saskia Bolz, Kathrin Kizina, et al.. (2020). Minimal clinically important differences in functional motor scores in adults with spinal muscular atrophy. European Journal of Neurology. 27(12). 2586–2594. 32 indexed citations
15.
Beyer, Léon, René Günther, Jan Christoph Koch, et al.. (2020). TDP‐43 as structure‐based biomarker in amyotrophic lateral sclerosis. Annals of Clinical and Translational Neurology. 8(1). 271–277. 20 indexed citations
16.
Kizina, Kathrin, Benjamin Stolte, Andreas Totzeck, et al.. (2020). Fatigue in adults with spinal muscular atrophy under treatment with nusinersen. Scientific Reports. 10(1). 11069–11069. 26 indexed citations
17.
Hagenacker, Tim, et al.. (2017). Schwann cells promote post-traumatic nerve inflammation and neuropathic pain through MHC class II. Scientific Reports. 7(1). 12518–12518. 58 indexed citations
18.
Hagenacker, Tim, et al.. (2010). Myricetin reduces voltage activated potassium channel currents in DRG neurons by a p38 dependent mechanism. Brain Research Bulletin. 83(5). 292–296. 13 indexed citations
19.
20.
Hagenacker, Tim, Frank Splettstoesser, Wolfgang Greffrath, Rolf‐Detlef Treede, & Dietrich Büsselberg. (2005). Capsaicin differentially modulates voltage-activated calcium channel currents in dorsal root ganglion neurones of rats. Brain Research. 1062(1-2). 74–85. 50 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Nobuyuki Murakami Breakdown of academic impact, for papers by Clifton L. Gooch Breakdown of academic impact, for papers by Yue Sun Breakdown of academic impact, for papers by Zheng Wei Breakdown of academic impact, for papers by Tomoya Terashima Breakdown of academic impact, for papers by Gisela Segond von Banchet Breakdown of academic impact, for papers by Luı́s F. Maia Breakdown of academic impact, for papers by Cora H. Nijboer Breakdown of academic impact, for papers by Xiaohuan Gu Breakdown of academic impact, for papers by Lusine Danielyan
Rankless by CCL
2026